Connection

Daniel Steinberg to Coronary Restenosis

This is a "connection" page, showing publications Daniel Steinberg has written about Coronary Restenosis.
Connection Strength

1.621
  1. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
    View in: PubMed
    Score: 0.309
  2. Impact of in-stent restenosis on death and myocardial infarction. Am J Cardiol. 2007 Oct 01; 100(7):1109-13.
    View in: PubMed
    Score: 0.277
  3. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. J Cardiovasc Comput Tomogr. 2016 Sep-Oct; 10(5):377-83.
    View in: PubMed
    Score: 0.129
  4. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
    View in: PubMed
    Score: 0.097
  5. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.084
  6. Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol. 2009 May; 21(5):210-4.
    View in: PubMed
    Score: 0.078
  7. Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era. Am J Cardiol. 2009 Apr 01; 103(7):950-3.
    View in: PubMed
    Score: 0.078
  8. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.078
  9. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
    View in: PubMed
    Score: 0.074
  10. Drug-eluting stent thrombosis. Minerva Cardioangiol. 2008 Feb; 56(1):127-37.
    View in: PubMed
    Score: 0.072
  11. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007 Oct; 20(5):307-13.
    View in: PubMed
    Score: 0.070
  12. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol. 2007 Sep 15; 100(6):965-9.
    View in: PubMed
    Score: 0.069
  13. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.069
  14. Drug-eluting stent thrombosis vs bare metal stent restenosis: finding the lesser of two evils. Am Heart Hosp J. 2007; 5(3):151-4.
    View in: PubMed
    Score: 0.067
  15. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
    View in: PubMed
    Score: 0.019
  16. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008 Aug 01; 102(3):298-303.
    View in: PubMed
    Score: 0.018
  17. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008 Feb 01; 101(3):293-9.
    View in: PubMed
    Score: 0.018
  18. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.